Clinical trial

ARNI Combined With SGLT2 Inhibitors on Functional Mitral Regurgitation Remodeling

NCT07379788

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-01-01

PhaseNA

Study timeline

Study start (actual)2025-01-01Date precision: day

Registry last updated2026-06-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Sacubitril/Valsartan 49 MG-51 MG Oral Tablet [ENTRESTO]DRUG

Empagliflozin10Mg TabDRUG

Sponsors & collaborators

Rehab Weridalead sponsor

Tanta Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07379788 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.